Propanc Biopharma Inc (PPCB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,913 | -1,103 | -617 | -2,658 | -1,753 |
| Depreciation Amortization | 1 | 1 | 1 | 2 | 2 |
| Accounts payable and accrued liabilities | 28 | 10 | 45 | 19 | -34 |
| Other Working Capital | 480 | 279 | 71 | 167 | 72 |
| Other Operating Activity | 476 | 79 | -9 | 1,034 | 689 |
| Operating Cash Flow | $-927 | $-735 | $-509 | $-1,436 | $-1,025 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 590 | 496 | 346 | 767 | 642 |
| Common Stock Issued | 400 | 225 | 125 | 724 | 475 |
| Other Financing Activity | 24 | 24 | 24 | 0 | 0 |
| Financing Cash Flow | $1,014 | $744 | $494 | $1,491 | $1,117 |
| Exchange Rate Effect | 3 | 11 | 30 | -53 | 40 |
| Beginning Cash Position | 4 | 4 | 4 | 2 | 2 |
| End Cash Position | 93 | 25 | 19 | 4 | 134 |
| Net Cash Flow | $89 | $20 | $15 | $2 | $132 |
| Free Cash Flow | |||||
| Operating Cash Flow | -927 | -735 | -509 | -1,436 | -1,025 |
| Free Cash Flow | -927 | -735 | -509 | -1,436 | -1,025 |